drugset / Trial / NCT06180876

Effect of Remimazolam on Postoperative Delirium

NCT06180876

Completed 264 enrolled Zhihong LU
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Remimazolam is a novel benzodiazepine with ultra-short onset and offset of its effect. It can be used for general anesthesia. However, classical benzodiazepine such as midazolam was reported to increase the risk of postoperative delirium. Thus, the investigators aim to investigate the effect of remimazolam general anesthesia on postoperative delirium in elderly patients.

Timeline

Start
2022-07-25
Primary completion
2024-01-25
Completion
2024-01-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 4 mg/kg
Comparator Propofol Small molecule 8 mg/kg
Subject Remimazolam Small molecule 0.7 mg/kg
Subject Remimazolam Small molecule 1.5 mg/kg

Indications

No indication recorded.